The Effects of Early Complementary Feeding on Growth, Neurodevelopment, Sleep and Gut Health

February 1, 2023 updated by: University of Colorado, Denver

The overall objective of this project is to understand how consuming a prescribed diet of different infant foods (which may contain cereals,fruits, vegetables, meats, dairy) during the time of early complementary feeding (~5 to 12 months) in breastfed infants has on growth trajectories, neurodevelopment and sleep patterns in relation to gut microbiota, compared with a traditional diet that is usually provided in the home to infants.

The three primary aims include:

Aim 1: Identify the effects that the prescribed early complementary feeding specific study diet has on growth trajectories in breastfed infants.

Aim 2: Identify whether the relationship between the prescribed early complementary feeding specific study diet and growth is mediated by gut microbiota.

Aim 3: Characterize infant neurodevelopment and sleep patterns.

Study Overview

Detailed Description

Some details are intentionally left to out to preserve the scientific integrity of the study, and they will be included in the record after the study is completed.

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Aurora, Colorado, United States, 80045
        • Recruiting
        • University of Colorado Anschutz Medical Campus

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 months to 6 months (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Full term: gestational age > 37 weeks
  • Exclusively breastfed (< 2 weeks of cumulative formula exposure). Any formula consumption on a given day is considered one day of formula exposure. During the intervention, if the participant receives more than 50% of the liquid diet from infant formula, s/he will be excluded from the study.
  • Maternal conditions such as gestational diabetes mellitus, preeclampsia, multiple pregnancies are acceptable.

Exclusion Criteria:

  • Large for gestational age or small for gestational age
  • Antibiotic use from birth to the time of enrollment
  • Documented food allergies
  • Previous complementary food exposure
  • Conditions that would affect protein metabolism or growth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Study Provided Diet
A group of complementary foods provided to participants by researchers.
Commercially available baby foods
PLACEBO_COMPARATOR: Traditional Diet
No study foods provided to participants by researchers. Participants will eat a typical diet provided by caregivers.
Caregiver will provide participant with usual foods from the home

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Weight
Time Frame: Over 6 months
Measured in kg
Over 6 months
Length
Time Frame: Over 6 months
Measured in cm
Over 6 months
Gut Microbiome
Time Frame: Over 6 months
Gut microbiota structure by 16S sequencing
Over 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body composition
Time Frame: Over 6 months
Body fat mass, fat-free mass measured by stable isotopes
Over 6 months
Total calories in breast milk
Time Frame: Over 6 months
Measured in kcal/100 mL
Over 6 months
Total carbohydrates in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Total protein in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Total fat in breast milk
Time Frame: Over 6 months
Measured in g/100 mL
Over 6 months
Serum IGF-1 (Insulin-like growth factor1/ somatomedin C)
Time Frame: Over 6 months
Measured in ng/mL
Over 6 months
Serum IGFBP-3 (Insulin-like growth factor-binding protein 3)
Time Frame: Over 6 months
Measured in ng/mL
Over 6 months
Serum c-reactive protein (CRP-hs)
Time Frame: Over 6 months
Measured in mg/L
Over 6 months
Dietary intake
Time Frame: Over 6 months
3 day dietary recall with results generated by NDSR software
Over 6 months
Neurodevelopment
Time Frame: At 12 months of age
Fine motor skills and cognition measured by the Bayley - III
At 12 months of age
Duration of sleep
Time Frame: Over 6 months
Measured in minutes per 24 hours by the MicroMini-Motionlogger actigraph
Over 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 15, 2020

Primary Completion (ANTICIPATED)

June 1, 2023

Study Completion (ANTICIPATED)

June 1, 2023

Study Registration Dates

First Submitted

October 17, 2019

First Submitted That Met QC Criteria

October 21, 2019

First Posted (ACTUAL)

October 24, 2019

Study Record Updates

Last Update Posted (ACTUAL)

February 2, 2023

Last Update Submitted That Met QC Criteria

February 1, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 19-0546
  • R01DK126710 (NIH)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gut Microbiome

Clinical Trials on Foods from the home

Subscribe